Terada T, Kiso M, Hasegawa A
Department of Applied Bioorganic Chemistry, Gifu University, Japan.
Carbohydr Res. 1994 Jun 17;259(2):201-18. doi: 10.1016/0008-6215(94)84058-x.
Analogues of sialyl-lactotetraosylceramide, sialyl-neolactotetraosylceramide, and sialyl Lewis X ganglioside, in which the N-acetylneuraminic acid residue is replaced by a 3-deoxy-D-glycero-D-galacto-2-nonulopyranosylonic acid (KDN) unit, have been synthesized. Methyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-alpha-D-galacto-2- nonulopyranosylonate)-(2-->3)-2,4,6-tri-O-benzoyl-1-thio-beta-D- galactopyranoside (4) was prepared from 2-(trimethylsilyl)ethyl O-(methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-alpha-D-galacto-2- nonulopyranosylonate)-(2-->3)-6-O-benzoyl-beta-D-galactopyranoside , via O-benzoylation, replacement of the 2-(trimethylsilyl)ethyl group by acetyl, and introduction of the methylthio group with trimethyl(methylthio)silane. Glycosylation of 2-(trimethylsilyl)ethyl O-(2-acetamido-4,6-O-benzylidene-2-deoxy-beta-D-glucopyranosyl)-(1-->3)- O- (2,4,6-tri-O-benzyl-beta-D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl- beta- D-glucopyranoside (5) or of 2-(trimethylsilyl)ethyl O-(2-acetamido-3,6-di-O-benzyl-2-deoxy-beta-D-glucopyranosyl)-(1-->3)-O- (2,4,6-tri-O-benzyl-beta-D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl- beta- D-glucopyranoside, prepared from 5 via O-benzylation and reductive opening of the benzylidene acetal ring, with 4 as a donor gave the corresponding pentasaccharides 9 and 13 in good yields. In the same way, 4 was reacted with 2-(trimethylsilyl)ethyl O-(2,3,4-tri-O-benzyl-alpha-L-fucopyranosyl)-(1-->3)-O-(2-acetamido-6- O-benzyl-2-deoxy-beta-D-glucopyranosyl)-(1-->3)-O-(2,4,6-tri-O-benzyl-be ta- D-galactopyranosyl)-(1-->4)-2,3,6-tri-O-benzyl-beta-D-glucopyranoside to yield the hexasaccharide 17. These three oligosaccharides 9, 13, and 17 were converted via reductive removal of the benzyl groups and benzylidene group, O-acetylation, removal of the 2-(trimethylsilyl)ethyl group, and subsequent reaction with trichloroacetonitrile, into the corresponding trichloroacetimidates 12, 16, and 20, respectively. Glycosylation of (2S,3R,4E)-2-azido-3-O-benzoyl-4-octadecene-1,3-diol with 12, 16, and 20 in the presence of boron trifluoride etherate afforded the expected beta-glycosides, which were transformed via selective reduction of the azido group, coupling with octadecanoic acid, O-deacylation, and de-esterification, into the target gangliosides in high yields.
已合成唾液酸乳糖四糖神经酰胺、唾液酸新乳糖四糖神经酰胺和唾液酸路易斯X神经节苷脂的类似物,其中N-乙酰神经氨酸残基被3-脱氧-D-甘油-D-半乳糖-2-壬酮糖醛酸(KDN)单元取代。O-(甲基4,5,7,8,9-五-O-乙酰基-3-脱氧-D-甘油-α-D-半乳糖-2-壬酮糖醛酸酯)-(2→3)-2,4,6-三-O-苯甲酰基-1-硫代-β-D-吡喃半乳糖苷(4)由2-(三甲基硅基)乙基O-(甲基4,5,7,8,9-五-O-乙酰基-3-脱氧-D-甘油-α-D-半乳糖-2-壬酮糖醛酸酯)-(2→3)-6-O-苯甲酰基-β-D-吡喃半乳糖苷通过O-苯甲酰化、用乙酰基取代2-(三甲基硅基)乙基以及用三甲基(甲硫基)硅烷引入甲硫基制备而成。2-(三甲基硅基)乙基O-(2-乙酰氨基-4,6-O-亚苄基-2-脱氧-β-D-吡喃葡萄糖基)-(1→3)-O-(2,4,6-三-O-苄基-β-D-吡喃半乳糖基)-(1→4)-2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷(5)或由5通过O-苯甲酰化和亚苄基缩醛环的还原开环制备的2-(三甲基硅基)乙基O-(2-乙酰氨基-3,6-二-O-苄基-2-脱氧-β-D-吡喃葡萄糖基)-(1→3)-O-(2,4,6-三-O-苄基-β-D-吡喃半乳糖基)-(1→4)-2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷与4作为供体进行糖基化反应,以良好的产率得到相应的五糖9和13。同样,4与2-(三甲基硅基)乙基O-(2,3,4-三-O-苄基-α-L-呋喃果糖基)-(1→3)-O-(2-乙酰氨基-6-O-苄基-2-脱氧-β-D-吡喃葡萄糖基)-(1→3)-O-(2,4,6-三-O-苄基-β-D-吡喃半乳糖基)-(1→4)-2,3,6-三-O-苄基-β-D-吡喃葡萄糖苷反应生成六糖17。这三种寡糖9、13和17通过苄基和亚苄基的还原去除、O-乙酰化、2-(三甲基硅基)乙基的去除以及随后与三氯乙腈反应,分别转化为相应的三氯乙亚胺酯12、16和20。在三氟化硼乙醚存在下,(2S,3R,4E)-2-叠氮基-3-O-苯甲酰基-4-十八碳烯-1,3-二醇与12、16和20进行糖基化反应,得到预期的β-糖苷,通过叠氮基的选择性还原、与十八烷酸偶联、O-脱酰基和脱酯化反应,以高产率转化为目标神经节苷脂。